Immunization production

Immunization—Production by artificial means of the capacity of the immune system to protect the body. 

Immunization procedures vary and are dependent on type of antigen to be used, duration of immunization process, and the amounts of immune product needed. The antigen suspension may be administered intravenously, intramuscularly, or subcutaneously. The amount of antigen injected can range from 1 to 200 mg. The quantity is determined by the availability of and the potency of the antigen. The time schedule also varies. Protocols for the three types of immunizations used to produce anti-carbohydrate antibodies are recorded in the following. 

Carcinogenic PAHs have been suggested to have an effect on immune function (Luster and Rosenthal 1993 Saboori and Newcombe 1992), thereby allowing the induction of carcinogenesis, while noncarcinogenic PAHs do not affect immue function (see Section 2.4). The effects of dermally applied benzo[a]pyrene alone or following dermal pretreatment with the prostaglandin synthetase inhibitor, indomethacin, on contact hypersensitivity (cell-mediated immunity), production of antibodies to DNP (humoral immunity), and the induction of skin tumors was studied in male BALBc... 

Non-specific immunity Product by general defenses, such as skin, lysozyme and complement, that protect against many different kinds of organisms rather than a specific one or two. 

In any case, I eventually recovered (and so did Jerry), but my immune system must have suffered serious damage, which manifested itself three years later, when I collapsed in my office one day and was found to be bleeding internally from a form of rare stomach cancer, which necessitated major surgery but was fortunately localized. I again recovered and have had no further difficulties since. Whether weakening and knocking out my immune system to overcome the previous problems had any effect is not clear, but it could have been a factor. Despite my health problems I was able to continue my work without much interruption, and the scientific productivity of my group has not... 

The separation of cells from the culture media or fermentation broth is the first step in a bioproduct recovery sequence. Whereas centrifugation is common for recombinant bacterial cells (see Centrifugal separation), the final removal of CHO cells utilizes sterile-filtration techniques. Safety concerns with respect to contamination of the product with CHO cells were addressed by confirming the absence of cells in the product, and their relative noninfectivity with respect to immune competent rodents injected with a large number of CHO cells. 

Contamination of blood products with lymphocytes can lead to transfusion-induced reactions ranging from a mild fever to severe reactions such as alloimmunization and graft versus host disease (GvHD), in which the transfused lymphocytes (graft) survive the defensive immune reaction of the patient (host) and start a reaction which destroys the cells of the host. The patient also may develop an immune response to the human leukocyte antigen (HLA) type of the graft s cells and reject all platelet transfusions that do not match their own HLA system. The HLA system, found on blood platelets and lymphocytes, is more compHcated than, but similar to, the ABO blood group system of red cells. 

One component of the age-ielated decline in immune function is decreased production of the lymphokine that promotes the growth of T-ceUs, interleukin 2 (IL-2). Administration of recombinant-derived IL-2, both in vitro and in vivo, appears to restore certain immune functions in aged mice. Recovery of T-regulatory effects on B-ceU differentiation has been reported in human cells from elderly patients treated with IL-1 and/or IL-2 (42). Similar effects have been observed in the presence of the pentapeptide thymopentin [69558-55-0] (Arg Lys Asp Val Tyr), a weU-known IL-2 inducer. Recombinant IL-2 adrninistered to aged mice for three weeks has been shown to correct the T-ceU functional deficiency associated with antigen-specific immunoglobulin production by certain lymphoid tissue (43). 

Finally, in another study related to nutrition and the immune response in the aged, old mice were given oral doses of two amino acids (qv), lysine and arginine. The treated mice showed evidences of recovered mitogenic responsiveness, expression of T-ceU markers, and production of thymic semm factor (thymulin). The effect of the amino acid combination, sold commercially as Neoiodarsolo, seems to consist mainly of the reactivation of the... 

---